FDA approval – Clinical Briefs – Levitra

FDA approval – Clinical Briefs – Levitra – Brief Article

Carrie Morantz

* Levitra. The U.S. Food and Drug Administration has approved vardenafil (Levitra) for the treatment of erectile dysfunction. Vardenafil helps increase blood flow to the penis and may help men with erectile dysfunction get and keep an erection satisfactory for sexual activity.

Vardenafil may be used once a day. Men taking nitrate drugs or alpha blockers should not use vardenafil. According to the manufacturer, the most commonly reported side effects are headache, flushing, and stuffy or runny nose. Vardenafil also can cause priapism and vision changes, such as seeing a blue tinge to objects.

Vardenafil is available in doses of 2.5 mg, 5 mg, 10 mg, and 20 mg. For most men, the recommended starting dose is 10 mg. Doses should be taken at least 24 hours apart, and one hour before sexual activity. Sexual stimulation is needed for an erection to occur.

COPYRIGHT 2003 American Academy of Family Physicians

COPYRIGHT 2003 Gale Group